IDT Biologika is a global contract development and manufacturing organization for vaccines, cell & gene therapeutics, and aseptic fill-finish of other biologics. This includes end-to-end services from process development through drug substance manufacturing up to BSL-2, sterile liquid dosage filling & lyophilization, labeling & packaging to quality control & analytics.
We offer clients in B2B business a single source CDMO partner at our sites in the USA and Germany, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. IDT Biologika handles every step in manufacturing and packaging of small clinical batches and large-scale commercial products.
Our fully integrated services are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP manufacturing capabilities meeting FDA, EMA and ANVISA standards.
We supply our client’s products in vials, pre-filled syringes, autoinjectors or as combination products.
May 22, 2023
Posted by IDT Biologika